Association between nucleoside and nucleotide reverse transcriptase inhibitor use and primary open-angle glaucoma risk in All of Us

IF 9.5 1区医学 Q1 OPHTHALMOLOGY

Ophthalmology Pub Date : 2025-06-21 DOI:10.1016/j.ophtha.2025.06.014

Kenneth Pham BA, Fangming Jin MS, Roy Lee MS, Isabel Di Rosa AB, Rebecca Salowe MSE, Gui-Shuang Ying PhD, Joan M. O’Brien MD

引用次数: 0

Abstract

To assess the association between the systemic use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) and primary open-angle glaucoma (POAG).

查看原文本刊更多论文

核苷和核苷酸逆转录酶抑制剂的使用与原发性开角型青光眼风险的关系

评估全身使用核苷和核苷酸逆转录酶抑制剂（NRTIs）与原发性开角型青光眼（POAG）之间的关系。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ophthalmology 医学-眼科学

CiteScore

22.30

自引率

3.60%

发文量

412

审稿时长

18 days

期刊介绍： The journal Ophthalmology, from the American Academy of Ophthalmology, contributes to society by publishing research in clinical and basic science related to vision.It upholds excellence through unbiased peer-review, fostering innovation, promoting discovery, and encouraging lifelong learning.